Table: Oncolys Biopharma -2023 parent forecast
Dec 15 (Reuters) -
Oncolys Biopharma Inc.
PARENT- ONLY EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Dec 31, 2023 Dec 31, 2023
LATEST PREVIOUS
FORECAST FORECAST
Sales 63 mln
Operating loss 1.81
Recurring loss 1.78
Net loss 1.78
EPS loss 92.20 yen
NOTE - Oncolys Biopharma Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4588.T